Duke researchers find that new immune therapy successfully treats brain tumors in mice
- Posted: December 18, 2012
Using an artificial protein that stimulates the body's natural immune system to fight cancer, a research team at Duke Medicine has engineered a lethal weapon that kills brain tumors in mice while sparing other tissue... The protein is manufactured with two arms, one that exclusively binds to tumor cells and another that snags the body's fighter T-cells, spurring an attack on the tumor.
Among the research institutions NCI funds across the United States, it currently designates 67 as Cancer Centers. Largely based in research universities, these facilities are home to many of the NCI-supported scientists who conduct a wide range of intense, laboratory research into cancer’s origins and development. The Cancer Centers Program also focuses on trans-disciplinary research, including population science and clinical research. The centers’ research results are often at the forefront of studies in the cancer field.